Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-22-017075

CEO and President gave up 3,215 shares (to pay taxes)

  • CEO and President acquired 13,204 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KLEMP WALTER V CEO and President 2022-07-11 Option exercise +13,204 235,650 D
KLEMP WALTER V CEO and President 2022-07-11 Shares withheld for taxes −3,215 $1.68 $5,401 232,435 D
Derivatives
KLEMP WALTER V CEO and President 2022-07-11 Option exercise · Restricted Stock Units −13,205 1,369,941 D
Loading xslF345X03/rdgdoc.xml…